PF3D7_1124200

PF3D7_1124200 (TRX2) is a thioredoxin-like protein that functions as a genuine, non-essential accessory component of the PTEX (Plasmodium translocon of exported proteins) complex, the machinery that exports parasite proteins across the parasitophorous vacuole membrane (PMID:23869529). Genetic tagging and co-localization confirmed its membership in PTEX, and knockout in P. berghei yielded viable parasites with reduced blood-stage growth in vivo and in vitro and diminished capacity to cause severe disease in a cerebral malaria model, establishing that TRX2 optimizes rather than being required for PTEX activity (PMID:23869529). It is expressed across multiple life-cycle stages including early gametocytes, mosquito, and liver stages, consistent with a role in protein export beyond asexual blood stages (PMID:23869529). Biochemically, in P. falciparum TRX2 is a poor substrate for thioredoxin reductase and lacks direct access to it, but can be reduced by the glutathione system, indicating it participates in cross-talk between the glutathione and thioredoxin antioxidant systems (PMID:28479253). Beyond its complex membership, redox biochemistry, and knockout phenotype, no further mechanistic detail on TRX2 has been characterized in the available corpus.

1. 2013 High

   Whether TRX2 is a bona fide PTEX component and whether it is required for parasite viability was unknown; tagging and knockout established it as a genuine, non-essential accessory subunit that optimizes export function.

   Evidence Epitope-tag knock-in with co-localization plus gene knockout in P. berghei assayed by in vivo/in vitro growth and a cerebral malaria model

   PMID:23869529

   Open questions at the time

   • Molecular contribution of TRX2 to translocation (e.g. substrate unfolding or redox handling within PTEX) not defined
   • Whether the growth defect stems from impaired export or a separate function is unresolved
   • Structural basis of TRX2 incorporation into PTEX not determined
2. 2013 Medium

   Whether TRX2 acts only in asexual blood stages was unknown; life-cycle expression profiling showed it is present in early gametocytes, mosquito, and liver stages, implying export function across the life cycle.

   Evidence Expression analysis across life-cycle stages using tagged lines

   PMID:23869529

   Open questions at the time

   • No direct functional consequence demonstrated for gametocyte, mosquito, or liver stages
   • Expression detected in a single lab via tagged lines only
3. 2017 Medium

   The redox partner that maintains TRX2 in its active state was unclear; in vitro reduction assays showed TRX2 is a poor thioredoxin reductase substrate but is reduced by the glutathione system, revealing antioxidant cross-talk.

   Evidence In vitro biochemical reduction assay measuring cross-system reduction of thioredoxins in P. falciparum

   PMID:28479253

   Open questions at the time

   • Single lab, single in vitro method; physiological relevance of glutathione-mediated reduction in vivo not tested
   • Link between TRX2 redox state and its role within PTEX not established
   • Native redox partner in the intact parasite not identified

• How TRX2's redox activity mechanistically contributes to PTEX-mediated protein export and whether it acts on specific exported substrates remains unknown.
• No substrate or redox target within the export pathway identified
• No structural model of TRX2 within PTEX
• Functional role in non-asexual stages not experimentally tested